Literature DB >> 28287645

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.

A T Nunes1, P Jain2, D E Kleiner3, N N Shah4, P Anandi2, F Chinian2, P Muranski2, M Battiwalla2, A J Barrett2, S Ito2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28287645      PMCID： PMC8171580          DOI： 10.1038/bmt.2017.38

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant.

Authors:  Rish K Pai; Koen van Besien; John Hart; Andrew S Artz; Peter H O'Donnell
Journal:  Leuk Lymphoma       Date:  2012-03-13

2.  Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.

Authors:  Ayman Akil; Qing Zhang; Christen L Mumaw; Nisha Raiker; Jeffrey Yu; Nieves Velez de Mendizabal; Laura S Haneline; Kent A Robertson; Jodi Skiles; Maribel Diaz-Ricart; Enric Carreras; Jamie Renbarger; Samir Hanash; Robert R Bies; Sophie Paczesny
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-11       Impact factor: 5.742

3.  Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.

Authors:  Mithun S Shah; Nandish Kumar S Jeevangi; Amit Joshi; Navin Khattry
Journal:  J Cancer Res Ther       Date:  2009 Oct-Dec       Impact factor: 1.805

4.  Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

Authors:  Alana A Kennedy-Nasser; Stephanie Ku; Paul Castillo-Caro; Yasmin Hazrat; Meng-Fen Wu; Hao Liu; Jos Melenhorst; A John Barrett; Sawa Ito; Aaron Foster; Barbara Savoldo; Eric Yvon; George Carrum; Carlos A Ramos; Robert A Krance; Kathryn Leung; Helen E Heslop; Malcolm K Brenner; Catherine M Bollard
Journal:  Clin Cancer Res       Date:  2014-02-26       Impact factor: 12.531

5.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Authors:  Mark T Vander Lugt; Thomas M Braun; Samir Hanash; Jerome Ritz; Vincent T Ho; Joseph H Antin; Qing Zhang; Chee-Hong Wong; Hong Wang; Alice Chin; Aurélie Gomez; Andrew C Harris; John E Levine; Sung W Choi; Daniel Couriel; Pavan Reddy; James L M Ferrara; Sophie Paczesny
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

6.  Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

Authors:  Lawrence Chang; David Frame; Thomas Braun; Erin Gatza; David A Hanauer; Shuang Zhao; John M Magenau; Kathryn Schultz; Hemasri Tokala; James L M Ferrara; John E Levine; Pavan Reddy; Sophie Paczesny; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-02       Impact factor: 5.742

7.  Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.

Authors:  Ulrike Fiedler; Yvonne Reiss; Marion Scharpfenecker; Verena Grunow; Stefanie Koidl; Gavin Thurston; Nicholas W Gale; Martin Witzenrath; Simone Rosseau; Norbert Suttorp; Astrid Sobke; Matthias Herrmann; Klaus T Preissner; Peter Vajkoczy; Hellmut G Augustin
Journal:  Nat Med       Date:  2006-02-05       Impact factor: 53.440

8.  Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.

Authors:  Kasiani C Myers; Christopher Dandoy; Javier El-Bietar; Stella M Davies; Sonata Jodele
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-06       Impact factor: 5.742

9.  Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.

Authors:  Paul G Richardson; Marcie L Riches; Nancy A Kernan; Joel A Brochstein; Shin Mineishi; Amanda M Termuhlen; Sally Arai; Stephan A Grupp; Eva C Guinan; Paul L Martin; Gideon Steinbach; Amrita Krishnan; Eneida R Nemecek; Sergio Giralt; Tulio Rodriguez; Reggie Duerst; John Doyle; Joseph H Antin; Angela Smith; Leslie Lehmann; Richard Champlin; Alfred Gillio; Rajinder Bajwa; Ralph B D'Agostino; Joseph Massaro; Diane Warren; Maja Miloslavsky; Robin L Hume; Massimo Iacobelli; Bijan Nejadnik; Alison L Hannah; Robert J Soiffer
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

10.  Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.

Authors:  P Anandi; X Tian; F Chinian; C R Cantilena; N Dunavin; N Hensel; D Draper; E Koklanaris; S Maxwell; J Superata; P Muranski; M Battiwalla; S Paczesny; A J Barrett; S Ito
Journal:  Bone Marrow Transplant       Date:  2016-09-05       Impact factor: 5.483
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.